Changes in prescribing and healthcare resource utilization after FDA Drug Safety Communications involving zolpidem‐containing medications

Purpose Products containing the sedative/hypnotic zolpidem were subject to Drug Safety Communications (DSCs) in January and May 2013 describing the risk of next‐morning impairment and recommending lower starting doses particularly for women. This study aimed to assess whether zolpidem DSCs were asso...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pharmacoepidemiology and drug safety 2017-06, Vol.26 (6), p.712-721
Hauptverfasser:	Kesselheim, Aaron S., Donneyong, Macarius, Dal Pan, Gerald J., Zhou, Esther H., Avorn, Jerry, Schneeweiss, Sebastian, Seeger, John D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Communications Dose-Response Relationship, Drug Drug Approval - methods Drug dosages Drug Prescriptions - standards Drug Safety Communications Female Formulations Gender Humans Hypnotics and Sedatives - therapeutic use Impairment interrupted‐time series Male Middle Aged Morning Patient Acceptance of Health Care Pharmacovigilance Product safety Pyridines - therapeutic use Resource utilization Risk assessment Safety United States - epidemiology Young Adult Zolpidem
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!